What's new

EMEA-001213-PIP03-23

EMEA-001213-PIP03-23

Mar 13, 2025 - 15:31
 0
EMEA-001213-PIP03-23
EMEA-001213-PIP03-23
Read More

Tags:

Previous Article

Tech Transformation: How Data Will Power Your Digital Adoption Journey

Next Article

25K hospital units show post-pandemic safety gains: 5 notes

Related Posts

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 April 2025, 11:00 (CEST) to 29 April 2025, 12:00 (CEST)

Questions and answers clinic on Product Management Serv...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Victoza, liraglutide, Date of authorisation: 30/06/2009, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive

Orphan designation: Rilzabrutinib Treatment of autoimmu...

Feb 20, 2025  0